<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Prediction of long-term diabetes remission after rygb, sleeve gastrectomy, and adjustable gastric banding using DiaRem and Advanced-DiaRem scores</dc:title>
  <dc:creator>Dicker, D.</dc:creator>
  <dc:creator>Golan, R.</dc:creator>
  <dc:creator>Aron-Wisnewsky, J.</dc:creator>
  <dc:creator>/Zucker, Jean-Daniel</dc:creator>
  <dc:creator>Sokolowska, N.</dc:creator>
  <dc:creator>Comaneshter, D. S.</dc:creator>
  <dc:creator>Yahalom, R.</dc:creator>
  <dc:creator>Vinker, S.</dc:creator>
  <dc:creator>Clement, K.</dc:creator>
  <dc:creator>Rudich, A.</dc:creator>
  <dc:subject>Diabetes remission</dc:subject>
  <dc:subject>Bariatric surgery</dc:subject>
  <dc:subject>Prediction score</dc:subject>
  <dc:description>Purpose DiaRem is a clinical scoring system designed to predict diabetes remission (DR) 1-year post-Roux-en-Y gastric bypass (RYGB). We examined long-term (2- and 5-year) postoperative DR prediction by DiaRem and an advanced-DiaRem (Ad-DiaRem) score following RYGB, sleeve gastrectomy (SG), and gastric banding (GB). Methods We accessed data from a computerized database of persons with type 2 diabetes and BMI &gt;= 30 kg/m(2) who underwent RYGB, SG, or GB, and determined DR status 2- and 5-year postoperative according to preoperative DiaRem and the Ad-DiaRem calculated scores. Results Among 1459 patients with 5-year postoperative diabetes status data, 53.6% exhibited DR. For RYGB, Ad-DiaRem trended to exhibit mildly improved predictive capacity 5-year postoperatively compared to DiaRem: Areas under receiver operating characteristic [AUROC] curves were 0.85 (0.76-0.93) and 0.78 (0.69-0.88), respectively. The positive predictive values (PPVs) detecting &gt;80% of those achieving DR (i.e., sensitivity &gt;= 0.8) were 78.2% and 73.2%, respectively, and higher Ad-DiaRem scores more consistently associated with decreased DR rates. Following SG, both scores had an AUROC of 0.82, but Ad-DiaRem still had a higher PPV for predicting &gt;80% of those with 5-year postoperative DR (76.2% and 71.0%). Predictive capacity parameters were comparatively lower, for both scores, when considering DR 5-year post-GB (AUROC: 0.73 for both scores, PPV: 66.3% and 64.3%, respectively). Conclusions Ad-DiaRem provides modest improvement compared to DiaRem in predicting long-term DR 5-years post-RYGB. Both scores similarly provide fair predictive capacity for 5-year postoperative DR after SG.</dc:description>
  <dc:date>2019</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010075538</dc:identifier>
  <dc:identifier>fdi:010075538</dc:identifier>
  <dc:identifier>Dicker D., Golan R., Aron-Wisnewsky J., Zucker Jean-Daniel, Sokolowska N., Comaneshter D. S., Yahalom R., Vinker S., Clement K., Rudich A.. Prediction of long-term diabetes remission after rygb, sleeve gastrectomy, and adjustable gastric banding using DiaRem and Advanced-DiaRem scores. 2019, 29 (3),  796-804</dc:identifier>
  <dc:language>EN</dc:language>
</oai_dc:dc>
